Teva to buy Allergan generic drug business for $40.5 billion, drops Mylan bid
Reuters
Teva Pharmaceutical Industries (TEVA) has agreed to buy Allergan Plc's (AGN) generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms
Reuters
Teva Pharmaceutical Industries (TEVA) has agreed to buy Allergan Plc's (AGN) generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms